Clinical studies should note the long-term (i.e., beyond 68 weeks) safety and effectiveness of semaglutide as it still needs to be fully understood
It includes consultations with a clinician and a medically appropriate treatment program, which can include medications
Most trials reported either no or minimal GSH adverse effects, but all had treatment durations of a few doses (IV) or 4 - 12 weeks
Conditions such as metabolic stress, acute or chronic inflammation or nutritional availability all might impact the regulation of GLP-1 from intestinal or pancreatic sources [13]
Iron deficiency Women of reproductive age already face higher iron demands than men, and reduced food intake on semaglutide compounds the risk
00:01:33 Don Weinberger: Just log in to your pharmacist letter, pharmacy technicians letter, or Prescriber Insights account and look for the title of this podcast in the list of available CE courses